journal article·2026-01Open access

Intestinal Neutral Ceramidase Deficiency Triggers Regulatory T Cell Response via Gd3 to Protect the Host from Intestinal Inflammation

Zhishan Xu, Chao Lei, Mukesh K Sriwastva, Ting Wang, Amanguli Tuohongerbieke, Xiaotong Song, Collin Noud, Shannon Derkson, Yi Tan, Gerald Dryden, Craig J McClain, Zhongbin Deng

Advanced Science· Volume 13· Issue 5

Abstract

Abstract Sphingolipids play a crucial role in gut inflammation. Neutral ceramidase (NcDase) serves as a pivotal regulator of ceramide, the central intermediate in sphingolipid metabolism. The contribution of intestinal epithelial cells (IEC) NcDase to colitis is not well understood. Here, a protective mechanism by which IEC NcDase deficiency ( Asah2 ΔIEC ) and its‐related gangliosides prevent dextran sulfate sodium (DSS)‐induced colitis in mice is described. Asah2 ΔIEC mice display reduced susceptibility to DSS‐induced colitis and increase regulatory T (T reg ) cells compared to Asah2 fl/fl littermates. Deletion of IEC NcDase induces the upregulation of sialyltransferase ST8SIA1 and promotes the sialic‐acid‐containing ganglioside GD3 production. Siglec‐E is a sialic‐acid‐binding lectin expresses predominantly on myeloid cells. Mechanistically, it is identified that GD3 is a functional ligand for Siglec‐E on macrophages and found that GD3/Siglec‐E interaction induced a rapid metabolic rewiring of macrophages that involved the production of IL‐33, which contributes to the generation of ST2 + Foxp3 + T reg cells. Finally, deletion of ST8SIA1 or administration of dietary GD3 induces or reduces mucosal inflammation, respectively. This work defines a critical role for ganglioside GD3 in the induction of colonic T reg cells and identifies an activating pathway that follows engagement of Siglec‐E.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Sphingolipid Metabolism and Signaling · Glycosylation and Glycoproteins Research · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Surgery Division of Immunotherapy University of Louisville Louisville KY 40202 USA

Brown Cancer Center University of Louisville Louisville KY 40202 USA

Department of Immunology School of Basic Medical Sciences Xinxiang Medical University Xinxiang 453003 China

Pediatric Research Institute Department of Pediatrics University of Louisville Louisville KY 40202 USA

Department of Medicine University of Louisville Louisville KY 40202 USA

Alcohol Research Center University of Louisville Louisville KY 40202 USA

Hepatobiology & Toxicology Center University of Louisville Louisville KY 40202 USA

Robley Rex VA Medical Center Louisville KY 40202 USA

Funding

National Institute of General Medical Sciences

References (40)

Show source-provided references
1. 10.1016/j.plipres.2008.04.00310.1016/j.plipres.2008.04.003 ↗
2. 10.1016/j.prostaglandins.2012.08.00310.1016/j.prostaglandins.2012.08.003 ↗
3. 10.1016/j.celrep.2022.11056010.1016/j.celrep.2022.110560 ↗
4. 10.1038/nrgastro.2014.7810.1038/nrgastro.2014.78 ↗
5. 10.1038/s41575-020-0331-710.1038/s41575-020-0331-7 ↗
6. 10.1042/bj2003023510.1042/bj20030235 ↗
7. 10.1074/jbc.M112.37100510.1074/jbc.M112.371005 ↗
8. 10.1073/pnas.96.16.914210.1073/pnas.96.16.9142 ↗
9. 10.1194/jlr.R00399610.1194/jlr.R003996 ↗
10. 10.1016/j.cell.2022.02.01310.1016/j.cell.2022.02.013 ↗
11. 10.1158/2326-6066.CIR-19-051410.1158/2326-6066.CIR-19-0514 ↗
12. 10.3748/wjg.v21.i35.1008010.3748/wjg.v21.i35.10080 ↗
13. 10.1155/2012/28028610.1155/2012/280286 ↗
14. 10.1177/014860711562009310.1177/0148607115620093 ↗
15. 10.1097/MPG.0b013e3181ae2ba010.1097/MPG.0b013e3181ae2ba0 ↗
16. 10.3389/fnut.2021.70517210.3389/fnut.2021.705172 ↗
17. 10.1038/nri373710.1038/nri3737 ↗
18. 10.1038/nri205610.1038/nri2056 ↗
19. 10.1074/jbc.M00278820010.1074/jbc.M002788200 ↗
20. 10.1038/ni151110.1038/ni1511 ↗
21. 10.1084/jem.2007060210.1084/jem.20070602 ↗
22. 10.1038/ni.370410.1038/ni.3704 ↗
23. 10.1038/nature1357710.1038/nature13577 ↗
24. 10.1016/j.immuni.2008.09.01810.1016/j.immuni.2008.09.018 ↗
25. 10.1053/j.gastro.2011.05.04910.1053/j.gastro.2011.05.049 ↗
26. 10.1038/mi.2009.1310.1038/mi.2009.13 ↗
27. 10.1038/ncomms914110.1038/ncomms9141 ↗
28. 10.1002/hep.3162810.1002/hep.31628 ↗
29. 10.1016/j.bbrc.2022.02.00410.1016/j.bbrc.2022.02.004 ↗
30. 10.1097/SHK.0b013e3180310fec10.1097/SHK.0b013e3180310fec ↗
31. 10.1093/glycob/cwj04610.1093/glycob/cwj046 ↗
32. 10.15252/embj.201910173210.15252/embj.2019101732 ↗
33. 10.1053/j.gastro.2005.03.04310.1053/j.gastro.2005.03.043 ↗
34. 10.1084/jem.2007059010.1084/jem.20070590 ↗
35. 10.1016/j.bbalip.2014.07.01310.1016/j.bbalip.2014.07.013 ↗
36. 10.1093/intimm/dxq43210.1093/intimm/dxq432 ↗
37. 10.1016/j.ajpath.2020.11.00410.1016/j.ajpath.2020.11.004 ↗
38. 10.1038/nprot.2017.04410.1038/nprot.2017.044 ↗
39. 10.1016/j.immuni.2015.06.02410.1016/j.immuni.2015.06.024 ↗
40. 10.1038/ncomms795610.1038/ncomms7956 ↗